Adrenergic pharmacology and cognition: Focus on the prefrontal cortex

Pharmacology and Therapeutics

Volumn 113, Issue 3, 2007, Pages 523-536

  Ramos, Brian P ^a   Arnsten, Amy F T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenoceptor; Betaxolol; cAMP; Clenbuterol; Frontal lobe; Guanfacine; Norepinephrine; Prazosin; Protein kinase C; Working memory

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETAXOLOL; CHELERYTHRINE; CLENBUTEROL; CLONIDINE; DEXAMPHETAMINE; DEXMEDETOMIDINE; GUANFACINE; LITHIUM; NEUROLEPTIC AGENT; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; ROLIPRAM; TAMOXIFEN; URAPIDIL; VALPROIC ACID;

ADRENERGIC ACTIVITY; AMYGDALOID NUCLEUS; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR CONTROL; BIPOLAR DEPRESSION; BRAIN CORTEX; BRAIN DYSFUNCTION; BRAIN FUNCTION; CATECHOLAMINE DEPLETION; COGNITION; HIPPOCAMPUS; HUMAN; INDUCED HYPOTENSION; KORSAKOFF PSYCHOSIS; LOCUS CERULEUS; LONG TERM MEMORY; LOW DRUG DOSE; MANIA; MENTAL DISEASE; NONHUMAN; PARKINSON DISEASE; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEDATION; SENSORY STIMULATION; SIDE EFFECT; THINKING; TRAUMATIC BRAIN INJURY; WORKING MEMORY;

COGNITION; HUMANS; LOCUS COERULEUS; MEMORY; MENTAL DISORDERS; NOREPINEPHRINE; PREFRONTAL CORTEX; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA;

EID: 33847631254     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2006.11.006     Document Type: Review

References (168)

1. Albert M.S. The ageing brain: normal and abnormal memory. Philos Trans R Soc Lond B 352 (1997) 1703-1709
2. Aoki C., Go C.-G., Venkatesan C., and Kurose H. Perikaryal and synaptic localization of alpha-2A-adrenergic receptor-like immunoreactivity. Brain Res 650 (1994) 181-204
3. Aoki C., Venkatesan C., Go C.-G., Forman R., and Kurose H. Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex 8 (1998) 269-277
4. Aoki C., Venkatesan C., and Kurose H. Noradrenergic modulation of the prefrontal cortex as revealed by electron microscopic immunocytochemistry. Adv Pharmacol 42 (1998) 777-780
5. Arikuni T., and Ban T. Subcortical afferents to the prefrontal cortex in rabbits. Exp Brain Res 32 (1978) 69-75
6. Arnsten A.F.T. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11 (1997) 151-162
7. Arnsten A.F.T. Stress impairs PFC function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog Brain Res 126 (2000) 183-192
8. Arnsten A.F.T. Through the looking glass: differential noradrenergic modulation of prefrontal cortical function. Neural Plast 7 (2000) 133-146
9. Arnsten A.F.T., and Contant T.A. Alpha-2 adrenergic agonists decrease distractability in aged monkeys performing a delayed response task. Psychopharmacology 108 (1992) 159-169
10. Arnsten A.F.T., and Goldman-Rakic P.S. Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res 306 (1984) 9-18
11. Arnsten A.F.T., and Goldman-Rakic P.S. Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230 (1985) 1273-1276
12. Arnsten A.F.T., and Goldman-Rakic P.S. Analysis of alpha-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys. Neurobiol Aging 11 (1990) 583-590
13. Arnsten A.F.T., and Robbins T.W. Neurochemical modulation of prefrontal cortical function in humans and animals. In: Stuss D.T., and Knight R.T. (Eds). In Principles of Frontal Lobe Function (2002), Oxford University Press, New York 51-84
14. Arnsten A.F.T., Cai J.X., and Goldman-Rakic P.S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects. J Neurosci 8 (1988) 4287-4298
15. Arnsten A.F., Steere J.C., and Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53 (1996) 448-455
16. Arnsten A.F.T., Mathew R., Ubriani R., Taylor J.R., and Li B.-M. Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry 45 (1999) 26-31
17. Aston-Jones G., Rajkowski J., and Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46 (1999) 1309-1320
18. Avery R.A., Franowicz J.S., Studholme C., van Dyck C.H., and Arnsten A.F.T. The alpha-2A-adenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology 23 (2000) 240-249
19. Baldessarini R.J., Huston-Lyons D., Campbell A., Marsh E., and Cohen B.M. Do central antiadrenergic actions contribute to the atypical properties of clozapine?. Br J Psychiatry 160 S17 (1992) 12-16
20. Bartus R.T., Fleming D., and Johnson H.R. Aging in the rhesus monkey: debilitating effects on short-term memory. J Gerontol 33 (1978) 858-871
21. Bebchuk J.M., Arfken C.L., Dolan-Manji S., Murphy J., and Manji H.K. A preliminary investigation of a protein kinase C inhibitor (Tamoxifen) in the treatment of acute mania. Arch Gen Psychiatry 57 (2000) 95-97
22. Birnbaum S.G., Gobeske K.T., Auerbach J., Taylor J.R., and Arnsten A.F.T. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in prefrontal cortex. Biol Psychiatry 46 (1999) 1266-1274
23. Birnbaum S.B., Yuan P., Bloom A., Davis D., Gobeske K., Sweatt D., et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306 (2004) 882-884
24. Boon-yasidhi V., Kim Y.S., and Scahill L. An open-label, prospective study of guanfacine in children with ADHD and tic disorders. J Med Assoc Thai 88 (2005) S156-S162
25. Breier A., Wolkowitz O., and Pickar D. Stress and schizophrenia: advances in neuropsychiatry and psychopharmacology. In: Tamminga C., and Schult S. (Eds). Schizophrenia Research. (1991), Raven Press, Ltd, New York
26. Bremner J.D. Neuroimaging studies in post-traumatic stress disorder. Curr Psychiatry Rep 4 (2002) 254-263
27. Bremner J.D., Innis R.B., Ng C.K., Staib L.H., Salomon R.M., Bronen R.A., et al. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 54 (1997) 246-254
28. Brozoski T., Brown R.M., Rosvold H.E., and Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205 (1979) 929-931
29. Cahill L., and McGaugh J.L. Modulation of memory storage. Curr Opin Neurobiol 6 (1996) 237-242
30. Cai J.X., Ma Y., Xu L., and Hu X. Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha-2 adrenergic agonist clonidine. Brain Res 614 (1993) 191-196
31. Carli M., Robbins T.W., Evenden J.L., and Everitt B.J. Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9 (1983) 361-380
32. Carlson S., Tanila H., Rama P., Mecke E., and Pertovaara A. Effects of medetomidine, an alpha-2 adrenoceptor agonist, and atipamezole, an alpha-2 antagonist, on spatial memory performance in adult and aged rats. Behav Neural Biol 58 (1992) 113-119
33. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., and Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311 (2006) 861-863
34. Chao L.L., and Knight R.T. Age-related prefrontal alterations during auditory memory. Neurobiol Aging 18 (1997) 87-95
35. Chappell P.B., Riddle M.A., Scahill L., Lynch K.A., Schultz R., Arnsten A., et al. Guanfacine treatment of comorbid attention deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psych 34 (1995) 1140-1146
36. Chaulk P.C., and Harley C.W. Intracerebroventricular norepinephrine potentiation of the perforant path-evoked potential in dentate gyrus of anesthetized and awake rats: a role for both alpha- and beta-adrenoceptor activation. Brain Res 787 (1998) 59-70
37. Clark C.R., Geffen G.M., and Geffen L.B. Catecholamines and attention: II. Pharmacological studies in normal humans. Neurosci Biobehav Rev 11 (1987) 353-364
38. Clark L., Roiser J.P., Cools R., Rubinsztein D.C., Sahakian B.J., and Robbins T.W. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) 182 (2005) 570-578
39. Cole B.J., and Robbins T.W. Forebrain norepinephrine: role in controlled information processing in the rat. Neuropsychopharmacology 7 (1992) 129-142
40. Collins P., Roberts A.C., Dias R., Everitt B.J., and Robbins T.W. Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex. J Cogn Neurosci 10 (1998) 332-354
41. Constantinidis C., Williams G.V., and Goldman-Rakic P.S. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci 5 (2002) 175-180
42. Coull J.T. Pharmacological manipulations of the a-2 noradrenergic system: effects on cognition. Drugs Aging 5 (1994) 116-126
43. Coull J.T., Frith C.D., Dolan R.J., Frackowiak R.S., and Grasby P.M. The neural correlates of the noradrenergic modulation of human attention, arousal and learning. Eur J Neurosci 9 (1997) 589-598
44. Coull J.T., Buchel C., Friston K.J., and Frith C.D. Noradrenergically mediated plasticity in a human attentional neuronal network. NeuroImage 10 (1999) 705-715
45. Crofts H.S., Dalley J.W., Collins P., van Denderen J.C.M., Everitt B.J., Robbins T.W., et al. Differential effects of 6-OHDA lesions of the prefrontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex 11 (2001) 1015-1026
46. Day H.E., Campeau S., Watson S.J.J., and Akil H. Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat 13 (1997) 115-139
47. De Santi S., de Leon M.J., Convit A., Tarshish C., Rusinek H., Tsui W.H., et al. Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatr Q 66 (1995) 357-370
48. Dohrenwend B.P., Shrout P.E., Link B.G., Skodol A.E., and Stueve A. Life events and other possible risk factors for episodes of schizophrenia and major depression: a case-control study. In: Mazure C.M. (Ed). Does Stress Cause Psychiatric Illness? (1995), American Psychiatric Press, Washington, D.C. 43-65
49. Duman R.S., and Nestler E.J. Signal transduction pathways for catecholamine receptors. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, N.Y. 303-320
50. Eberling J.L., Roberts J.A., Rapp P.R., Tuszynski M.H., and Jagust W.J. Cerebral glucose metabolism and memory in aged rhesus macaques. Neurobiol Aging 18 (1997) 437-443
51. Elrod R., Peskind E.R., DiGiacomo L., Brodkin K.I., Veith R.C., and Raskind M.A. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiatr 154 (1997) 25-30
52. Engberg G., and Eriksson E. Effects of alpha-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated rats. Naunyn Schmiedebergs Arch Pharmacol 343 (1991) 472-477
53. Erdely H.A., Tamminga C.A., Roberts R.C., and Vogel M.W. Regional alterations in RGS4 protein in schizophrenia. Synapse 59 (2006) 472-479
54. Ferry B., and McGaugh J.L. Clenbuterol administration into the basolateral amygdala post-training enhances retention in an inhibitory avoidance task. Neurobiol Learn Mem 72 (1999) 8-12
55. Ferry B., Roozendaal B., and McGaugh J.L. Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction between beta- and alpha-1-adrenoceptors. J Neurosci 19 (1999) 5119-5123
56. Ferry B., Roozendaal B., and McGaugh J.L. Involvement of alpha-1-adrenoceptors in the basolateral amygdala in modulation of memory storage. Eur J Pharmacol 372 (1999) 9-16
57. Fields R.B., Van Kammen D.P., Peters J.L., Rosen J., Van Kammen W.B., Nugent A., et al. Clonidine improves memory function in schizophrenia independently from change in psychosis. Schizophr Res 1 (1988) 417-423
58. Fillenz M., and Lowry J.P. Studies of the source of glucose in the extracellular compartment of the rat brain. Dev Neurosci 20 (1998) 365-368
59. Fillenz M., Lowry J.P., Boutelle M.G., and Fray A.E. The role of astrocytes and noradrenaline in neuronal glucose metabolism. Acta Physiol Scand 167 (1999) 275-284
60. Finlay J.M., Zigmond M.J., and Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64 (1995) 619-628
61. Foote S.L., Aston-Jones G., and Bloom F.E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. PNAS 77 (1980) 3033-3037
62. Franowicz J.C.S., and Arnsten A.F.T. The alpha-2A noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys. Psychopharmacology 136 (1998) 8-14
63. Franowicz J.S., and Arnsten A.F.T. Treatment with the noradrenergic alpha-2 agonist clonidine, but not diazepam, improves spatial working memory in normal young rhesus monkeys. Neuropsychopharmacology 21 (1999) 611-621
64. Franowicz J.S., Kessler L., Morgan C., and Arnsten A.F.T. The alpha-2 noradrenergic agonist, guanfacine, improves spatial working memory in wild type mice but not mice with point mutations of the gene for the alpha-2A receptor. Soc Neurosci Abstr 24 (1998) 711
65. Friedman J.I., Adler D.N., and Davis K.L. The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol Psychiatry 46 (1999) 1243-1252
66. Gerfen C.R., and Clavier R.M. Neural inputs to the prefrontal agranular insular cortex in the rat: horseradish peroxidase study. Brain Res Bull 4 (1979) 347-353
67. Goldman P.S., and Rosvold H.E. Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp Neurol 27 (1970) 291-304
68. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 14 (1995) 477-485
69. Goldman-Rakic P.S., Lidow M.S., and Gallager D.W. Overlap of dopaminergic, adrenergic, and serotonergic receptors and complementarity of their subtypes in primate prefrontal cortex. J Neurosci 10 (1990) 2125-2138
70. Goldstein L.E., Rasmusson A.M., Bunney S.B., and Roth R.H. Role of the amygdala in the coordination of behavioral, neuroendocrine and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 16 (1996) 4787-4798
71. Gottfries C.-G., Adolfsson R., Aquilonius S.-M., Carlsson A., Eckernas S.-A., Nordberg A., et al. Biochemical changes in dementia disorders of Alzheimer's type (AD/SDAT). Neurobiol Aging 4 (1983) 261-271
72. Hammen C., and Gitlin M. Stress reactivity in bipolar patients and its relation to prior history of disorder. Am J Psychiatr 154 (1997) 856-857
73. Hansson E., and Ronnback L. Receptor regulation of the glutamate, GABA and taurine high-affinity uptake into astrocytes in primary culture. Brain Res 548 (1991) 215-221
74. Hieble J.P., Bylund D.B., Clarke D.E., Eikenburg D.C., Langer S.Z., Lefkowitz R.J., et al. International Union of Pharmacology: X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev 47 (1995) 267-270
75. Horrigan J.P. Guanfacine for PTSD nightmares. J Am Acad Child Adolesc Psych 35 (1996) 975-976
76. Horrigan J.P., and Barnhill L.J. Guanfacine for treatment of Attention-Deficit-Hyperactivity Disorder in boys. J Am Acad Child Adolesc Psych 5 (1995) 215-223
77. Hunt R.D., Mindera R.B., and Cohen D.J. Clonidine benefits children with attention deficit disorder and hyperactivity: reports of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Adolesc Psych 24 (1985) 617-629
78. Hunt R.D., Arnsten A.F.T., and Asbell M.D. An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psych 34 (1995) 50-54
79. Insel P.A. Adrenergic receptors, G proteins, and cell regulation: implications for aging research. Exp Gerontol 28 (1993) 341-348
80. Introini-Collison I.B., Miyazaki B., and McGaugh J.L. Involvement of the amygdala in the memory-enhancing effects of clenbuterol. Psychopharmacology 104 (1991) 541-544
81. Jackson W.J., and Buccafusco J.J. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacol Biochem Behav 39 (1991) 79-84
82. Jakala P., Riekkinen M., Sirvio J., Koivisto E., Kejonen K., Vanhanen M., et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology 20 (1999) 460-470
83. Jakala P., Sirvio J., Riekkinen M., Koivisto E., Kejonen K., Vanhanen M., et al. Guanfacine and clonidine, alpha-2 agonists, improve paired associates learning, but not delayed matching to sample, in humans. Neuropsychopharmacology 20 (1999) 119-130
84. Jodo E., Chiang C., and Aston-Jones G. Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 83 (1998) 63-79
85. Korol D.L., and Gold P.E. Glucose, memory, and aging. Am J Clin Nutr 67 (1998) 764-771
86. Krystal J.H., Deutsch D.N., and Charney D.S. The biological basis of panic disorder. Clin Psychiatry 57 S10 (1996) 23-31
87. Kulkarni J., Garland K.A., Scaffidi A., Headey B., Anderson R., de Castella A., et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 31 (2006) 543-547
88. Lacaille J.C., and Harley C.W. The action of norepinephrine in the dentate gyrus: beta-mediated facilitation of evoked potentials in vitro. Brain Res 358 (1985) 210-220
89. Lawlor B.A., Bierer L.M., Ryan T.M., Schmeidler J., Knott P.J., Williams L.L., et al. Plasma MHPG and clinical symptoms in Alzheimer's disease. Biol Psychiatry 38 (1995) 185-188
90. Lewis D.A., and Morrison J.H. Noradrenergic innervation of monkey prefrontal cortex: a dopamine-beta-hydroxylase immunohistochemical study. J Comp Neurol 282 (1989) 317-330
91. Li B.-M., and Mei Z.-T. Delayed response deficit induced by local injection of the alpha-2 adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav Neural Biol 62 (1994) 134-139
92. Li B.-M., Mao Z.-M., Wang M., and Mei Z.-T. Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys. Neuropsychopharmacology 21 (1999) 601-610
93. Lipska B.K., Mitkus S., Caruso M., Hyde T.M., Chen J., Vakkalanka R., et al. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Hum Mol Genet 15 (2006) 2804-2812
94. Luine V., Bowling D., and Hearns M. Spatial memory deficits in aged rats: contributions of monoaminergic systems. Brain Res 537 (1990) 271-278
95. Ma C.L., Qi X.L., Peng J.Y., and Li B.M. Selective deficit in no-go performance induced by blockade of prefrontal cortical alpha 2-adrenoceptors in monkeys. NeuroReport 14 (2003) 1013-1016
96. Ma C.L., Arnsten A.F., and Li B.M. Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys. Biol Psychiatry 57 (2005) 192-195
97. MacDonald E., Kobilka B.K., and Scheinin M. Gene targeting-homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci 18 (1997) 211-219
98. Mair R.G., and McEntree W.J. Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with 1-dopa and ephedrine. Psychopharmacology 88 (1986) 374-380
99. Manji H.K., and Lenox R.H. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46 (1999) 1328-1351
100. Mao Z.-M., Arnsten A.F.T., and Li B.-M. Local infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol Psychiatry 46 (1999) 1259-1265
101. In: Mazure C.M. (Ed). Does Stress Cause Psychiatric Illness? (1995), American Psychiatric Press, Washington, D.C.
102. McAllister T.W., Flashman L.A., Sparling M.B., and Saykin A.J. Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment-a review. Brain Inj 18 (2004) 331-350
103. McClure, M. S., Barch, D. M., Romero, M. J., Minzenberg, M. J., Triebwasser, J., Harvey, P. D., et al. (in press). The Effects of Guanfacine on Context Processing Abnormalities in Schizotypal Personality Disorder. Biol Psychiatry (Online).
104. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., and Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6 (2001) 293-301
105. Moffoot A., O'Carroll R.E., Murray C., Dougall N., Ebmeier K., and Goodwin G.M. Clonidine infusion increases uptake of Tc-exametazime in anterior cingulate cortex in Korsakoff's psychosis. Psychol Med 24 (1994) 53-61
106. Mohell N., Svartengren J., and Cannon B. Identification of [3H]prazosin binding sites in crude membranes and isolated cells of brown adipose tissue as alpha-1 adrenergic receptors. Eur J Pharmacol 92 (1983) 15-25
107. Mohr E., Schlegel J., Fabbrini G., Williams J., Mouradian M., Mann U.M., et al. Clonidine treatment of alzheimer's disease. Arch Neurol 46 (1989) 376-378
108. Morrison J.H., Molliver M.E., and Grzanna R. Noradrenergic innervation of cerebral cortex: widespread effects of local cortical lesions. Science 205 (1979) 313-316
109. Morrison J.H., Foote S.L., O'Connor D., and Bloom F.E. Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: dopamine-beta-hydroxylase immunohistochemistry. Brain Res Bull 9 (1982) 309-319
110. Mouradian R.D., Seller F.M., and Waterhouse B.D. Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: evidence of mediation by an alpha1-receptor-linked second messenger pathway. Brain Res 546 (1991) 83-95
111. Muller U., Clark L., Lam M.L., Moore R.M., Murphy C.L., Richmond N.K., et al. Lack of effects of guanfacine on executive and memory functions in healthy male volunteers. Psychopharmacology (Berl) 182 (2005) 205-213
112. Nicholas A.P., Pieribone V.A., and Hokfelt T. Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience 56 (1993) 1023-1039
113. Nielsen-Bohlman L., and Knight R.T. Prefrontal alterations during memory processing in aging. Cereb Cortex 5 (1995) 541-549
114. Noda A., Ohba H., Kakiuchi T., Futatsubashi M., Tsukada H., and Nishimura S. Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys. Brain Res 936 (2002) 76-81
115. Ordway G.A., O'Donnell J.M., and Frazer A. Effects of clenbuterol on Beta-1 and Beta-2 adrenergic receptors of the rat. J Pharmacol Exp Ther 241 (1987) 187-195
116. O'Rourke M.F., Blaxall H.S., Iversen L.J., and Bylund D.B. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 268 (1994) 1362-1367
117. Peskind E.R., Bonner L.T., Hoff D.J., and Raskind M.A. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder. J Geriatr Psychiatry Neurol 16 (2003) 165-171
118. Pieribone V.A., Nicholas A.P., Dagerlind A., and Hokfelt T. Distribution of alpha1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J Neurosci 14 (1994) 4252-4268
119. Porrino L.J., and Goldman-Rakic P.S. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J Comp Neurol 205 (1982) 63-76
120. Posner M.I., Walker J.A., Friedrich F.J., and Rafal R.D. Effects of parietal injury on covert orienting of visual attention. J Neurosci 4 (1984) 1863-1874
121. Post R.M., Gordon E.K., Goodwin F.K., and Bunney W.E. Central norepinephrine metabolism in affective illness: MHPG in the cerebrospinal fluid. Science 179 (1973) 1002-1003
122. Prasad K.M., Chowdari K.V., Nimgaonkar V.L., Talkowski M.E., Lewis D.A., and Keshavan M.S. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry 10 (2005) 213-219
123. Rainbow T.C., Parsons B., and Wolfe B.B. Quantitative autoradiography of beta1- and beta2-adrenergic receptors in rat brain. Proc Natl Acad Sci U S A 81 (1984) 1585-1589
124. Rajkowski J., Kubiak P., Inanova S., and Aston-Jones G. State-related activity, reactivity of locus coeruleus neurons in behaving monkeys. Adv Pharmacol 42 (1998) 740-744
125. Rama P., Linnankoski I., Tanila H., Pertovaara A., and Carlson S. Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys. Pharmacol Biochem Behav 54 (1996) 1-7
126. Ramos B., Birnbaum S.B., Lindenmayer I., Newton S.S., Duman R., and Arnsten A.F.T. Dysregulation of protein kinase A signaling in the aged prefrontal cortex: New strategy for treating age-related cognitive decline. Neuron 40 (2003) 835-845
127. Ramos B.P., Colgan L., Nou E., Ovadia S., Wilson S.R., and Arnsten A.F.T. The β-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys. Biol Psychiatry 58 (2005) 894-900
128. Ramos B.P., Stark D., Verduzco L., van Dyck C.H., and Arnsten A.F.T. Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals. Learn Mem 13 (2006) 770-776
129. Ramos, B. P., Colgan, L. A., Nou, E., & Arnsten, A. F. T., (in press). The β2 adrenergic agonist, clenbuterol, can enhance working memory performance in aging rats and monkeys. Neurobiol Aging.
130. Rao S.G., Williams G.V., and Goldman-Rakic P.S. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20 (2000) 485-494
131. Raskind M.A., Dobie D.J., Kanter E.D., Petrie E.C., Thompson C.E., and Peskind E.R. The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J Clin Psychiatry 61 (2000) 129-133
132. Raskind M.A., Peskind E.R., Kanter E.D., Petrie E.C., Radant A., Thompson C., et al. Prazosin reduces nightmares and other PTSD symptoms in combat veterans: a placebo-controlled study. Am J Psychiatr 160 (2003) 371-373
133. Riekkinen M., and Riekkinen P.J. Alpha2-adrenergic agonist clonidine for improving spatial working memory in Parkinson's disease. J Clin Psychopharmacol 19 (1999) 444-449
134. Riekkinen P., and Riekkinen M. THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's Disease. Neuropsychopharmacology 20 (1999) 357-364
135. Roberts A.C., Salvia M.A., Wilkinson L.S., Collins P., Muir J.L., Everitt B.J., et al. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: possible interactions with subcortical dopamine. Neuroscience 14 (1994) 2531-2544
136. Roullet P., and Sara S. Consolidation of memory after its reactivation: involvement of beta noradrenergic receptors in the late phase. Neural Plast 6 (1998) 63-68
137. Runyan J.D., Moore A.N., and Dash P.K. A role for prefrontal calcium-sensitive protein phosphatase and kinase activities in working memory. Learn Memory 12 (2005) 103-110
138. Sahakian B.J., Sarna G.S., Kantamaneni B.D., Jackson A., Hutson P.H., and Curzon G. Association between learning and cortical catecholamines in non-drug-treated rats. Psychopharmacology 86 (1985) 339-343
139. Sallinen J., Haapalinna A., MacDonald E., Viitamaa T., Lahdesmaki J., Rybnikova E., et al. Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels. Mol Psychiatry 4 (1999) 443-452
140. Sara S.J., and Herve-Minvielle A. Inhibitory influence of frontal cortex on locus coeruleus. Proc Natl Acad Sci U S A 92 (1995) 6032-6036
141. Sara S.J., Roullet P., and Przybyslawski J. Consolidation of memory for odor-reward association: beta-adrenergic receptor involvement in the late phase. Learn Memory 6 (1999) 88-96
142. Sawaguchi T. Attenuation of delay-period activity of monkey prefrontal cortical neurons by an alpha-2 adrenergic antagonist during an oculomotor delayed-response task. J Neurophysiol 80 (1998) 2200-2205
143. Scahill L., Chappell P.B., Kim Y.S., Schultz R.T., Katsovich L., Shepherd E., et al. Guanfacine in the treatment of children with tic disorders and ADHD: a placebo-controlled study. Am J Psychiatr 158 (2001) 1067-1074
144. Schacter D.L., Savage C.R., Alpert N.M., Rauch S.L., and Albert M.S. The role of hippocampus and frontal cortex in age-related memory changes: a PET study. NeuroReport 7 (1996) 1165-1169
145. Schildkraut J.J. Biogenic amines and affective disorders. Annu Rev Med 25 (1974) 333-348
146. Simon H. Dopaminergic A10 neurons and the frontal system. J Physiol 77 (1981) 81-95
147. Sirviö J., Riekkinen P., Vajanto I., Koivisto E., and Riekkinnen P.J. The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task. Behav Neural Biol 56 (1991) 101-107
148. Smith K.M., Daly M., Fischer M., Yiannoutsos C.T., Bauer L., Barkley R., et al. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Genet B Neuropsychiatr Genet 119 (2003) 77-85
149. Southwick S.M., Krystal J.H., Bremner J.D., Morgan C.A.r., Nicolaou A.L., Nagy L.M., et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 54 (1997) 749-758
150. Southwick S.M., Morgan C.A.r., Bremner J.D., Grillon C.G., Krystal J.H., Nagy L.M., et al. Noradrenergic alterations in posttraumatic stress disorder. Ann NY Acad Sci 821 (1997) 125-141
151. Steere J.C., and Arnsten A.F.T. The alpha-2A noradrenergic agonist, guanfacine, improves visual object discrimination reversal performance in rhesus monkeys. Behav Neurosci 111 (1997) 1-9
152. Summers R.J., Papaioannou M., Harris S., and Evans B.A. Expression of beta 3-adrenoceptor mRNA in rat brain. Br J Pharmacol 116 (1995) 2547-2548
153. Swartz B.E., Kovalik E., Thomas K., Torgersen D., and Mandelkern M.A. The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy. Neuropsychopharmacology 23 (2000) 263-275
154. Talkowski M.E., Seltman H., Bassett A.S., Brzustowicz L.M., Chen X., Chowdari K.V., et al. Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 60 (2006) 152-162
155. Tang Y., Buxbaum S.G., Waldman I., Anderson G.M., Zabetian C.P., Kohnke M.D., et al. A single nucleotide polymorphism at DBH, possibly associated with attention-deficit/hyperactivity disorder, associates with lower plasma dopamine beta-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 60 (2006) 1034-1038
156. Tanila H., Rama P., and Carlson S. The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats. Brain Res Bull 40 (1996) 117-119
157. Tanila H., Mustonen K., Sallinen J., Scheinin M., and Riekkinen P. Role of alpha-2C-adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the alpha-2C-adrenoceptor gene. Eur J Neurosci 11 (1999) 599-603
158. Taylor F., and Raskind M.A. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol 22 (2002) 82-85
159. Taylor F.B., and Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention deficit-hyperactivity disorder. J Clin Psychopharmacol 21 (2001) 223-228
160. Taylor J.R., Birnbaum S.G., Ubriani R., and Arnsten A.F.T. Activation of protein kinase A in prefrontal cortex impairs working memory performance. J Neurosci (Online) 19 (1999) RC23
161. Taylor F., Lowe K., Thompson C., McFall M.M., Peskind E.R., Kanter E.D., et al. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry 59 (2006) 577-581
162. Vaiva G., Ducrocq F., Jezequel K., Averland B., Lestavel P., Brunet A., et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 54 (2003) 947-949
163. Wang, M., Ramos, B. P., Paspalas, C., Simen, A., Duque, A., Vijayraghavan, S., et al. (in press). α2A-Adrenoceptor stimulation strengthens working memory networks by inhibiting cAMP production and closing HCN channels in prefrontal cortex. Cell.
164. Waterhouse B.D., Moises H.C., and Woodward D.J. Noradrenergic modulation of somatosensory cortical neuronal responses to iontophoretically applied putative transmitters. Exp Neurol 69 (1980) 30-49
165. Waterhouse B.D., Moises H.C., and Woodward D.J. Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology 20 (1981) 907-920
166. Witte E.A., and Marrocco R.T. Alterations of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting. Psychopharmacology 132 (1997) 315-323
167. Young L.T., Walsh J.J., Kish S.J., Shannek K., and Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 35 (1994) 121-127
168. Zhang H.T., Huang Y., Mishler K., Roerig S.C., and O'Donnell J.M. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats. Psychopharmacology (Berl) 182 (2005) 104-115